Vascular Sealant Global Market Report 2026

A vascular sealant is a medical adhesive formulated to achieve hemostasis by closing blood vessels and stopping bleeding. It generally comprises synthetic or biologically sourced materials that create a stable barrier when applied to blood or tissue. These sealants assist in tissue healing and help lower the risk of hemorrhage during surgical procedures.

The primary product types of vascular sealant include fibrin sealants, collagen-based sealants, synthetic sealants, and other product types. Fibrin sealants refer to biologically derived adhesives that replicate the natural blood clotting mechanism to achieve hemostasis and tissue sealing during surgical procedures. These products are developed using material types such as natural biological materials, synthetic polymeric materials, and semi-synthetic materials, and are available in form factors including liquid, patch, spray or foam, and pre-filled applicator kits. They find application in cardiovascular surgery, general surgery, neurosurgery, orthopedic surgery, and other applications, serving end users including hospitals, ambulatory surgical centers, specialty clinics, and other end users.

Tariffs are influencing the vascular sealant market by increasing costs of key raw materials such as biological components and synthetic polymers, which is resulting in higher prices for sealant products. This has significantly impacted segments like fibrin sealants and synthetic sealants, with Asia-Pacific and Europe facing supply chain constraints due to heavy reliance on imported materials. Clinical applications in cardiovascular and general surgery are experiencing cost pressures and slower adoption rates. However, tariffs are also promoting domestic biomaterial production, strengthening local manufacturing capabilities, and encouraging innovation in more affordable and alternative sealant formulations.

The vascular sealant market research report is one of a series of new reports from The Business Research Company that provides vascular sealant market statistics, including vascular sealant industry global market size, regional shares, competitors with a vascular sealant market share, detailed vascular sealant market segments, market trends and opportunities, and any further data you may need to thrive in the vascular sealant industry. This vascular sealant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular sealant market size has grown strongly in recent years. It will grow from $1.71 billion in 2025 to $1.85 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rising number of surgical procedures, increasing prevalence of cardiovascular diseases, advancements in surgical technologies, growing demand for effective hemostasis solutions, expansion of healthcare infrastructure.

The vascular sealant market size is expected to see strong growth in the next few years. It will grow to $2.51 billion by 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing adoption of minimally invasive surgeries, rising demand for advanced biomaterials, growing investment in surgical innovation, expansion of outpatient surgical centers, increasing focus on patient safety and faster recovery. Major trends in the forecast period include increasing adoption of advanced hemostatic agents in surgeries, rising preference for minimally invasive surgical sealants, growing demand for fast-acting and high-strength vascular sealants, development of bioresorbable and biocompatible sealant materials, expansion of multi-application sealants across surgical specialties.

The increasing prevalence of cardiovascular disease is expected to drive the growth of the vascular sealant market going forward. Cardiovascular disease refers to a group of disorders that affect the heart and blood vessels, including conditions such as ischemic heart disease and stroke. The prevalence of cardiovascular diseases is rising due to population aging and growth, along with increased exposure to risk factors such as obesity, diabetes, high blood pressure, poor diet, sedentary lifestyles, and smoking, which collectively elevate the risk of heart and blood vessel disorders. Vascular sealants help manage cardiovascular disease by enabling effective control of bleeding, supporting vascular repair, and reducing complications during surgical procedures. For instance, according to the Scottish Health Survey 2024 by the Scottish Government, a Scotland-based government administration, 16% of adults reported living with any cardiovascular disease (CVD), with prevalence increasing from 4% among individuals aged 16-24 to 42% among adults aged 75 and over. Therefore, the rising prevalence of cardiovascular disease is driving the growth of the vascular sealant market.

Leading companies operating in the vascular sealant market are focusing on leveraging innovative technologies such as grip technology to achieve faster hemostasis and improved patient recovery. Grip technology, a hydrophilic polymer-based system, forms a secure and flexible seal at the vascular access site, helping achieve rapid hemostasis, minimizing the risk of bleeding complications, reducing patient recovery time, and enabling earlier ambulation and discharge, while providing a minimally invasive alternative to traditional manual compression methods. For example, in July 2024, Cordis Corporation, a US-based medical device company, received U. S. Food and Drug Administration (FDA) approval for the Mynx Control Venous VCD, an innovative device that leverages Grip Technology based on hydrophilic, bioinert polyethylene glycol. The Mynx Control Venous VCD provides effective closure for midbore venous puncture sites, including those used in electrophysiology procedures, and demonstrated 100% procedural and device success in clinical trials. Key benefits include significantly reduced time to hemostasis (2.1 minutes versus 11.4 minutes for manual compression), faster amb

In January 2026, Haemonetics Corporation, a US-based medical technology company, acquired Vivasure Medical Limited for an undisclosed consideration. With this acquisition, Haemonetics seeks to broaden its portfolio of large-bore vascular closure devices, strengthen its technological capabilities in minimally invasive vascular procedures, accelerate innovation in structural heart and endovascular therapies, and expand its global customer base in interventional cardiology and vascular surgery. Vivasure Medical Limited is an Ireland-based medical technology company specializing in the development of vascular sealant.

Major companies operating in the vascular sealant market are Johnson & Johnson, Pfizer Inc., Medtronic plc, Stryker Corporation, Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Grifols S. A., Terumo Corporation, Teleflex Incorporated, Integra LifeSciences Holdings Corporation, CSL Behring LLC, Advanced Medical Solutions Group plc, SkinStitch Inc., Tricol Biomedical Inc., Cellphire Therapeutics Inc., Artivion Inc., GluStitch Inc., CuraMedical B. V., Endomedix Inc.

North America was the dominating region in the vascular sealant market in 2025. Asia-Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the vascular sealant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vascular sealant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vascular sealant market consists of sales of polyethylene glycol sealants, cyanoacrylate adhesives, albumin-based sealants, collagen-based hemostatic sealants, thrombin-based sealants, gelatin-based sealants, bioabsorbable vascular sealants, hemostatic patches, surgical sealant applicators, dual syringe delivery systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vascular Sealant Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses vascular sealant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vascular sealant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular sealant market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Fibrin Sealants; Collagen Based Sealants; Synthetic Sealants; Other Product Types
• 2) By Material Type: Natural Biological Materials; Synthetic Polymeric Materials; Semi Synthetic Materials
• 3) By Form Factor: Liquid; Patch; Spray Or Foam; Pre Filled Applicator Kits
• 4) By Application: Cardiovascular Surgery; General Surgery; Neurosurgery; Orthopedic Surgery; Other Applications
• 5) By End User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Fibrin Sealants: Human Plasma Derived Sealants; Bovine Plasma Derived Sealants; Recombinant Fibrin Sealants; Combination Fibrin Sealants
• 2) By Collagen Based Sealants: Bovine Collagen Sealants; Porcine Collagen Sealants; Equine Collagen Sealants; Crosslinked Collagen Sealants
• 3) By Synthetic Sealants: Polyethylene Glycol Sealants; Cyanoacrylate Sealants; Albumin Based Sealants; Gelatin Based Sealants
• 4) By Other Product Types: Combination Sealants; Hydrogel Sealants; Polysaccharide Based Sealants; Enzymatic Sealants
• Companies Mentioned: Johnson & Johnson; Pfizer Inc.; Medtronic plc; Stryker Corporation; Becton Dickinson and Company; Baxter International Inc.; B. Braun Melsungen AG; Grifols S.A.; Terumo Corporation; Teleflex Incorporated; Integra LifeSciences Holdings Corporation; CSL Behring LLC; Advanced Medical Solutions Group plc; SkinStitch Inc.; Tricol Biomedical Inc.; Cellphire Therapeutics Inc.; Artivion Inc.; GluStitch Inc.; CuraMedical B.V.; Endomedix Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.